Innervace

Private

New York City, New YorkHealthcare & Life Scienceshttps://innervace.com

Last Round

Series A

Sep 8, 2022

Total Funding Raised

$41.1M

Company Overview

Innervace is a biotechnology company that develops implantable tissue-engineered brain pathways for the treatment of neurodegenerative disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

regenerative medicinecell therapytissue engineeringbiofabricationneural pathway reconstructionParkinson's disease treatmentneurodegenerative therapybrain circuitry repairimplantable neural scaffoldbiotech startupbrain repairneuro-regenerationbio-implant

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Innervace Comps

Public and private peers based on sector, stage, and business model.

Innervace comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Innervace Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Sep 8, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Nader Halim

Chief Executive Officer

Executive Team

Innervace Investors

Notable investors and investment history

Innervace investors
Investor	Rounds
Deerfield Management	Series A
IP Group	Series A
WARF Ventures	Series A
Bio-Reference Laboratories, Inc.	Series A
WARF	Series A
Anzu Partners	Series A
Longview Innovation	Series A

View all Investors

Innervace Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Innervace Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Innervace's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York

Employee Range1

Year Founded2018

Last FundingSep 8, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.